Details

Autor(en) / Beteiligte

• Okuda, Yusuke
• Shimura, Takaya
• Uno, Konomu
• Yamada, Tomonori
• Nukui, Takayuki
• Mizushima, Takashi
• Takenaka, Yuya
• Itoh, Keisuke
• Inagaki, Yuki
• Ozeki, Takanori
• Nagao, Kazuhiro
• Ebi, Masahide
• Uchida, Erika
• Nomura, Satoshi
• Nojiri, Yu
• Togawa, Shozo
• Sugimura, Naomi
• Fukusada, Shigeki
• Iwasaki, Hiroyasu
• Katano, Takahito
• Kataoka, Hiromi

Titel

A multicenter case–control study of self-expanding metallic stent versus trans-anal colorectal tube for stage II/III non-right-sided obstructive colon cancer

Ist Teil von

• Journal of gastroenterology, 2023-03, Vol.58 (3), p.217-228

Ort / Verlag

Singapore: Springer Nature Singapore

Erscheinungsjahr

2023

Link zum Volltext

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Background Self-expanding metallic stent (SEMS) and trans-anal colorectal tube (TCT) are alternative treatments to conventional emergency surgery for non-right-sided obstructive colon cancer (NROCC). However, the one with better short- and long-term outcomes remains controversial. Thus, this multicenter case–control study aimed to analyze and compare SEMS and TCT for NROCC. Methods Patients with stage II/III NROCC who underwent surgery between January 2010 and December 2019 at either of the eight selected Japanese affiliate hospitals were, retrospectively, reviewed. Baseline characteristics between the SEMS and TCT groups were adjusted by propensity score (PS) matching. Results Among 239 reviewed patients (SEMS: 76, TCT: 163), 180 were finally included in two well-balanced cohorts through PS: SEMS group (65 patients) and TCT group (115 patients). Technical success, clinical success, morbidity, and short-term mortality were not significantly different between the two groups. SEMS placement achieved significantly higher rates for primary resection/anastomosis without stoma (SEMS: 90.8% vs. TCT: 77.4%, p  < 0.001) and laparoscopic surgery (SEMS: 64.6% vs. TCT: 43.5%, p  < 0.001) than TCT placement. However, 5-year overall survival (SEMS: 83.7% vs. TCT: 86.4%; p  = 0.822) and 5-year relapse-free survival (SEMS: 64.7% vs. TCT: 66.4%; p  = 0.854) showed no significant differences between these groups. Conclusions Both SEMS and TCT revealed similar long-term outcomes, but SEMS placement was better in achieving primary resection/anastomosis and laparoscopic surgery in patients with stage II/III NROCC.